» Articles » PMID: 27654843

Reinventing HCV Treatment: Past and Future Perspectives

Overview
Publisher Wiley
Specialty Pharmacology
Date 2016 Sep 23
PMID 27654843
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

This review paper summarizes the epidemiology of hepatitis C virus (HCV) and chronic HCV infection, including HCV virology and treatment regimens. Specifically, we focus on the evolution of past, current, and future HCV treatment options, the reasons for treatment failure, and the impact of resistance-associated variants on treatment success.

Citing Articles

Should they wait? Two children under 3 years old infected by HCV 1b successfully treated by ledipasvir/sofosbuvir: A report of two cases.

Li M, Wulayin K, Lin S, Wu C, Chen L Liver Res. 2025; 7(4):361-364.

PMID: 39958777 PMC: 11791916. DOI: 10.1016/j.livres.2023.11.001.


Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States.

Auty S, Griffith K, Shafer P, Gee R, Conti R J Health Polit Policy Law. 2022; 47(6):691-708.

PMID: 35867531 PMC: 9789167. DOI: 10.1215/03616878-10041121.


Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post-Liver Transplant in a Real-World Population.

Hawkins K, Hot I J Pharm Technol. 2021; 34(5):199-203.

PMID: 34860992 PMC: 6109861. DOI: 10.1177/8755122518782478.


Seroprevalence, Genotyping, and Monitoring of Hepatitis C Viral Loads in Patients on Antivirals in Burkina Faso.

Yelemkoure E, Yonli A, Sombie H, Tao I, Zoure A, Ouattara A Intervirology. 2021; 65(3):151-159.

PMID: 34583364 PMC: 9501785. DOI: 10.1159/000519848.


The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam.

McCabe L, White I, Vinh Chau N, Barnes E, Pett S, Cooke G Trials. 2020; 21(1):413.

PMID: 32423467 PMC: 7236096. DOI: 10.1186/s13063-020-04350-x.